Actively Recruiting
Evaluating Safety and Effectiveness of ButyMixx Supplement for Adults with Ulcerative Colitis in Remission
Led by University of Padova · Updated on 2026-05-15
40
Participants Needed
1
Research Sites
12 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying a dietary supplement called ButyMixx to see if it can help people with ulcerative colitis who are in remission feel better and reduce inflammation in their intestines. Ulcerative colitis is a chronic condition causing inflammation of the colon, and even when symptoms are minimal, the intestines can remain fragile and prone to flare-ups. The study explores whether ButyMixx can improve symptoms, quality of life, and balance the gut microbiota, which is often disrupted in these patients. ButyMixx combines sodium butyrate, a substance naturally produced by gut bacteria that supports intestinal lining health and reduces inflammation, with a beneficial yeast called Kluyveromyces marxianus, similar to probiotics. Participants will take two sachets of ButyMixx daily for eight weeks. The study includes two visits one at the start and one after eight weeks, during which stool samples will be collected, and symptoms and quality of life will be assessed. Participants will provide stool samples before and after the treatment period to measure intestinal inflammation and gut microbiota balance. They will complete a quality-of-life questionnaire and have their symptoms evaluated by a doctor. Researchers will monitor for any medical problems related to taking ButyMixx to assess its safety and tolerability. The total study duration for each participant is eight weeks.
CONDITIONS
Brief Title
Sodium Butyrate and Kluyveromyces Marxianus Supplementation in Inflammatory Bowel Disease
Research Team
E
Edoardo V Savarino
S
Sonia Facchin
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here